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1. Introduction 
The generation of DNA damage by environmental, medical or life style factors is considered 
to be an important initial event in carcinogenesis. At the cellular level, a balance between the 
production of oxidative radicals and the compensational action of antioxidants, which might 
become pro-oxidant at high concentrations (Anderson et al., 1994) is crucial for our health. 
Imbalance on either side, especially towards an increase in oxidative stress, might result in 
various detrimental effects including cell death and cancer. Despite various cellular 
mechanisms to counteract these adverse events the sheer number of potentially carcinogenic 
compounds leading to oxidative stress can negatively affect the DNA integrity of cells.  
Dietary flavonoids acting as antioxidants (Rice-Evans, 2001) have been identified to be 
capable of counteracting these adverse oxidative effects (Ross and Kasum, 2002). They are 
classified as low-molecular-weight polyphenolic compounds that are ubiquitously present 
in fruit and vegetables and categorised according to their chemical structure into flavonols, 
flavones, flavanones, isoflavones, catechins, anthocyanidins and chalcones. Flavonoids such 
as quercetin and rutin present in soybean products have potent antioxidant properties and 
mimic oestrogens, hence are being used to ease menopausal symptoms. Soy flavonoids are 
also believed to lower the blood level of triglicerydes and cholesterol preventing coronary 
heart disease as well as osteoporosis (Valachovicova et al., 2004). They have a wide variety 
of biological effects acting either as anti- or pro-oxidants depending on their concentration 
(Anderson et al., 1997; Duthie et al., 1997) and/or in combination with food mutagens 
(Anderson et al., 1997). Anderson et al. observed positive responses with flavonoids when 
lymphocytes were treated with them alone in the Comet assay, and in combination with 
food mutagens they were showing exacerbating effects at low doses and were protective at 
high doses (Anderson et al., 1997). The antioxidant potency of several widespread dietary 
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flavonoids showed a dose-dependent reduction of induced oxidative DNA damage in vitro, 
highlighting an even higher protective effect than vitamin C (Noroozi et al., 1998). It has also 
been shown that flavonoid intake can lower the mortality rate caused by coronary heart 
disease (Kaur et al., 2007). Typical flavonoids are kaempferol, quercetin and rutin (the 
common glycoside of quercetin), belonging to the class of flavonols. The strongest evidence 
for a cancer-preventive effect shows quercetin with strong antioxidant properties 
(Chondrogianni et al., 2010; Hollman et al., 1996). It has been reported that the average 
intake of flavonoids is 23 mg per day with quercetin contributing almost 70% (Hollman et 
al., 1996; Wach et al., 2007). As it scavenges highly reactive species such as peroxynitrite and 
hydroxyl radicals (Boots et al., 2008), quercetin protects not only against various diseases 
such as atherosclerosis, cancer, osteoporosis, pulmonary and cardiovascular diseases but 
also against ageing (Chondrogianni et al., 2010; Ekstrom et al., 2010; Ossola et al., 2009; 
Terao, 2009; Zhou et al., 2010).  
Lifestyle factors like alcohol intake, physical inactivity, stress, food additives, high animal 
fat and/or red meat intake and also cooking-derived carcinogens such as heterocyclic 
amines (HCA), have been identified as having a strong impact on human health and being 
involved in the aetiology of cancer in general (Adamson et al., 1996; Bogen, 1994). Evidence 
for a positive association of colorectal cancer and adenomatous polyps with HCA exposure 
has been provided by several studies (Butler et al., 2003; Felton et al., 2007; Gunter et al., 
2005; Knize and Felton, 2005; Murtaugh et al., 2004; Navarro et al., 2004; Nowell et al., 2002; 
Shin et al., 2007; Wu et al., 2006). HCA are formed by cooking proteinaceous food, mainly 
seen as heat-induced non-enzymatic browning that involves creatinine, free amino acids 
and monosaccharides (Schut and Snyderwine, 1999). More than 20 carcinogenic/mutagenic 
HCA have been isolated so far (Nagao et al., 1997; Wakabayashi et al., 1992). Major 
subclasses of HCA found in the human diet comprise of aminoimidazoazaarenes (AIA), 2-
amino-3-methylimidazo[4,5-f]quinoline (IQ), 2-amino-3,4-dimethylimidazo[4,5-f]quinoline 
(MeIQ), 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx), 2-amino-3,4,8-
trimethylimidazo[4,5-f]quinoxaline (DiMeIQx) and 2-amino-1-methyl-6-phenylimidazo[4,5-
b]pyridine (PhIP) (Schut and Snyderwine, 1999). It has been estimated that the daily intake 
of HCA can reach 50 µg (Knize et al., 1995; Krul et al., 2000), depending on the type of meat, 
temperature and the method of cooking (Messner and Murkovic, 2004; Wu et al., 2001). The 
heterocyclic amine PhIP is considered to be the most abundant HCA responsible for 
inducing various types of tumours in rats (Felton et al., 2004). 
More than 600 individual compounds and complex dietary mixtures have been studied for 
protective effects towards HCA (Schwab et al., 2000) and numerous articles have been 
published regarding mammalian enzymes involved in the bioactivation and detoxification 
of these compounds (Eisenbrand and Tang, 1993). The genotoxicity of HCA originates from 
their activation by a series of reactions involving cytochrome P450 when the parent 
compound is converted to an electrophilic derivative such as a nitrenium ion that covalently 
binds to DNA resulting in DNA adducts and subsequently in nucleotide alterations and 
chromosomal aberrations (Goldman and Shields, 2003; Hatch et al., 2001). IQ induces 
unscheduled DNA synthesis in liver cells and shows strong mutagenic properties in the 
Salmonella typhimurium test system, which contribute to its classification as a potent 
carcinogen (Maeda et al., 1999; Murata et al., 1999; Weisburger et al., 1986) Also in addition 
to the formation of DNA adducts, oxidative damage to the DNA itself plays a crucial role in 
the carcinogenic process of food mutagens (Maeda et al., 1999; Murata et al., 1999). 
Heterocyclic amines like IQ are able to generate free radicals in the presence of NADPH and 
cytochrome b5 reductase (Maeda et al., 1999).  
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Colorectal tissue is constantly exposed to different chemicals and free oxygen radicals 
formed during metabolic activation. High intracolonic levels of free radicals may form 
active carcinogens or mitogenic tumour promoters through the oxidation of procarcinogens, 
either by hydroxyl radicals in faecal water or by secondary peroxyl radicals (Babbs, 1990). 
Within an inflamed bowel, disproportionate amounts of reactive oxygen species (ROS) can 
be additionally produced (Loguercio et al., 1996; Simmonds and Rampton, 1993). Ulcerative 
Colitis and Crohn's disease are inflammatory disorders of the gastrointestinal tract, 
associated with increased risk for colorectal cancer (Soderlund et al., 2010), which are 
unevenly distributed within the populations throughout the world. Although the exact 
cause of inflammatory bowel disease (IBD) remains unknown, the epidemiology of IBD has 
provided an insight into the pathogenesis of the disease by examining geographic, ethnic 
and other IBD risk factors (genetic, environmental, etc.) as well as their natural history 
(Danese and Fiocchi, 2006). Interestingly, reactive oxygen species (Seegert et al., 2001) are 
produced in abnormally high levels in cells from IBD patients (Rezaie et al., 2007) leading to 
oxidative stress and thus to DNA damage due to an imbalance between innate and 
exogenous antioxidants and ROS (Hemnani and Parihar, 1998; Soffler, 2007). Oxidative 
stress has been linked to cancer, aging, atherosclerosis, ischemic injury, inflammation and 
neurodegenerative diseases (Davies, 1995). Oxidative stress arising from the 
pathophysiology of cancer, may even serve as a biomarker (Hopkins et al., 2010), when 
there is an imbalance between production of ROS and their removal by intrinsic 
antioxidants (catalase) and antioxidant micronutrients.  
In the present study, we used the Comet assay, which evaluates direct DNA breaks and is a 
fast and reliable method to assess DNA integrity in virtually any cell type without the 
requirement for cell culture (Moller, 2006). Three groups of individuals served as blood 
donors: healthy volunteers, IBD patients as well as patients with histopathologically 
confirmed, untreated colon cancer. It is known that lymphocytes from colon cancer patients 
exhibit higher levels of DNA damage caused by the intrinsic oxidative stress arising from 
colorectal cancer (Hopkins et al., 2010) and that these lymphocytes may also serve as an 
early predictive marker of cancer risk (Vodicka et al., 2010). Separated lymphocytes from 
IBD patients and healthy individuals were treated with H2O2 co-treated with quercetin and 
IQ with epicatechin. Also lymphocytes from colon cancer patients and healthy individuals 
were treated with IQ and PhIP with and without the supplementation of the antioxidant 
flavonoids, quercetin and rutin to show that these three flavonoids are able to reliably 
protect cells against the damaging effects of reactive oxygen species, even in the context of 
diseases like IBD or colorectal cancer where levels of ROS are already highly increased. 
Non-physiological doses were used in vitro to study the genotoxicological responses where 
higher, yet non cytotoxic doses are used as a routine procedure. 
2. Materials and methods 
2.1 Chemicals 
The chemicals for the Comet assay were purchased from the following suppliers: RPMI-1640 
medium, agarose and low melting point agarose from Invitrogen, Ltd. (Paisley, U.K.); 
DMSO (dimethyl sulfoxide), ethidium bromide, Trypan blue, EDTA, Trizma base, Triton X-
100, quercetin, epicatechin, rutin and hydrogen peroxide H2O2, from Sigma Chemical 
Company (Dorset, U.K.); sodium chloride and sodium hydroxide from BDH Laboratory 
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Supplies (Poole, England); Lymphoprep cell separation gel from Nycomed Pharma Axis 
Shield (Oslo, Norway); FCS (foetal calf serum) from Nalgene, Rochester (New York, USA). 
The food mutagens, IQ (2-amino-3-methyl-3h-imidazo[4,5-f]quinoline) and PhIP (2-amino-1-
methyl-6-phenylimidazo[4,5-b]pyridine), were obtained from Toronto Research Chemicals, 
Inc. (Downsview, Ontario, Canada). 
2.2 Collection of samples 
After informed consent, approximately 10 ml heparinised blood were taken by 
venepuncture from the IBD and colon cancer patients at the Department of 
Gastroenterology, Bradford Royal Infirmary (BRI) and St. Luke’s Hospital, Bradford, UK. 
Healthy volunteers were recruited within the Division of Biomedical Sciences at the 
University of Bradford (West Yorkshire, UK). Ethical permission was obtained from both 
the BRI Local Ethics Committee (Reference no.: 04/Q1202/15) and the University of 
Bradford’s Sub-Committee for Ethics in Research involving Human Subjects (Reference no.: 
0405/8). Over a period of three years, a set of samples from healthy controls, IBD patients 
and colon cancer patients was obtained.  
2.3 Questionnaire for patients and controls 
A questionnaire was administered to each donor immediately after taking the blood sample. 
The completed questionnaire for the patient and control groups provided essential 
information about lifestyle, endogenous (gender, age) and exogenous factors (intake of 
medicines and alcohol, smoking habits and diet). There were two different studies 
performed: study I involving IBD patients and study II – colorectal cancer patients. Both 
studies had separate treatment regimes.  
2.4 Lymphocyte separation for the Comet assay 
The heparinised blood was diluted with 0.9% saline in a 50:50 proportion and 6 ml of this 
dilution was carefully layered on top of 3 ml of Lymphoprep in 15 ml conical tubes followed 
by centrifugation (20 minutes at 800 g) at room temperature. The buffy coat layer of 
lymphocytes (above the Lymphoprep layer) was then transferred to another tube pre-filled 
with 10 ml of saline and centrifuged (15 minutes at 500 g). The supernatant was removed 
without disturbing the pellet which was then resuspended in PBS or RPMI-1640 medium 
and used for the in vitro experiments. Some of the lymphocytes were frozen in liquid 
nitrogen for long-term storage. In this case the pellet was resuspended in FCS containing 
10% DMSO, and lodged in liquid nitrogen vapour overnight, before final storage after 
complete insertion in the storage Dewar. 
2.5 Cell viability  
Cell viability at the concentrations chosen for each experiment was checked after treatment 
and before performing the Comet assay. Viability was determined by Trypan blue dye 
exclusion indicating intact cell membranes (Phillips, 1973). 10 µl of 0.05% Trypan blue was 
added to 10 µl of cell suspension and the percentage of cells excluding the dye was 
estimated using a Neubauer Improved haemocytometer (Pool-Zobel et al., 1992). Only 
concentrations with viability over 80% were accepted for use in the studies to avoid 
artefactual results from cytotoxicity (Henderson et al., 1998). 
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2.6 Treatment of lymphocytes 
2.6.1 Treatment for IBD group of experiments  
Isolated lymphocytes (approx. 106 cells per ml) from IBD patients (n=10) and healthy 
controls (n=10) were treated without metabolic activation for 30 minutes in RPMI at 37 ºC 
either with different concentrations of quercetin (0, 100, 200, 250 µM) in the presence of 
hydrogen peroxide (50 µM) or with different concentrations of epicatechin (0, 25, 50, 100 
µM) in the presence of IQ (50 µM). Lymphocytes from healthy individuals served as the 
control groups. After the treatment, the cells were pelleted (5 minutes at 900 g). For DNA 
damage studies, the cell suspension was mixed with the same volume of 1% low melting 
point agarose for the Comet assay. 
2.6.2 Treatment for colorectal cancer group of experiments 
Lymphocyte suspensions (100 µl, 106 cells per ml) from colon cancer patients (n=20) and 
healthy controls (n=20) were exposed to defined concentrations of food mutagens and/or 
flavonoids in the presence of RPMI in a total volume of 1 ml. The treatment was for 30 min 
at 37 °C. As lymphocytes showed little or no difference in response with metabolic 
activation, the Comet assay was performed in the absence of metabolic activation to avoid 
any confounding factors (Anderson, 1997, 1998). To investigate DNA damage, the following 
concentrations were used 10, 25, 50 and 75 µM for PhIP and 25, 75, 100 and 150 µM for IQ 
based on preliminary studies (data not shown). To investigate the modulatory effect of 
flavonoids, the highest concentrations of IQ and PhIP were used for simultaneous 
combination treatment with the flavonoids, quercetin and rutin, supplemented at 
concentrations of 100 (50 for rutin), 250 and 500 µM. 
2.7 Alkaline comet assay 
The slide preparation for the Comet assay and the assay itself was carried out as previously 
described (Tice et al., 2000). An aliquot of 100 µl of lymphocyte suspension was mixed with 
100 µl of 1% low melting point agarose (in PBS, <40 °C warm) and 100 µl of this suspension 
were spread onto each of the two microscope glass slides pre-coated with 1% normal 
melting point agarose (in water, dried overnight). After cover-slips were applied, the slides 
were placed on an ice-cold tray. Once the agarose set, the cover-slips were removed and a 
final third layer of 0.5% low melting point agarose (in PBS) was added and allowed to 
solidify as well on ice for 5 min. For each concentration, two replicate slides were produced. 
For cell lysis, the slides were immersed laterally in a container with cold lysing solution (2.5 
M NaCl, 100 mM EDTA, 10 mM Tris, 10% DMSO, 1% Triton X-100, pH 10) and incubated at 
4 ºC overnight. Then, the slides were placed on the tray of an electrophoresis tank, filled 
with cold alkaline electrophoresis buffer (300 mM NaOH, 1 mM EDTA, pH <13) and 
incubated for 30 minutes at 4 ºC in the dark to allow the unwinding of DNA and expression 
of alkali labile sites. Electrophoresis was conducted at the same temperature for 30 minutes 
at 0.75 V/cm. The current was adjusted to 300 mA by raising or lowering the buffer level. 
After electrophoresis, the slides were removed from the tank and soaked three times for 5 
minutes each with neutralizing Tris buffer (400 mM, pH 7.4). Cellular DNA was stained 
with 60 µl of 20 µg/ml ethidium bromide and cover-slips applied. Slides were examined 
using a fluorescence microscope equipped with a charge couple device (CCD) monochrome 
camera and a computerised image analysis system, Komet 4.0 (Kinetic Imaging, Liverpool, 
UK) to measure the comet parameters. All slides were coded by an independent person 
ensuring that scoring took place completely randomized and in a “blind” manner (Faust et 
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al., 2004). For each replicate slide, 25 cells were scored (50 cells in total) for each individual 
in each group making 500-1000 observations per experimental point, allowing a more than 
adequate statistical power to detect effects (Hartmann et al., 2003). 
2.8 Statistical analysis  
Data were tested for normality prior to statistical analysis. Normal distributions were 
checked through the Kolmogorov-Smirnoff and Shapiro-Wilk’s Test to assess whether 
parametric statistics could be used. Study I: Gaussian normality was violated for many of 
the scale variables as endorsed by the Kolmogorov-Smirnov test. Therefore, non-parametric 
test procedures were adopted wherever necessary, such as the Kruskal-Wallis (K-W) and the 
Mann-Whitney (M-W) tests for independent samples. When testing intra-subject differences 
in DNA damage, the Wilcoxon Signed Rank (WSR) test was applied. For the binary 
response variables, Fisher's Exact (FE) test was applied. Throughout the analyses, a 
significance level of 5% was used and unilateral alternative hypotheses preferred to 
bidirectional tests (wherever appropriate). Study II: differences in measured parameters 
between healthy and colon cancer subjects were assessed by the parametric One Way 
ANOVA Test, since data were normally distributed. The relationship between DNA damage 
and various parameters characterising colon cancer status and unexposed control was 
analyzed using Post-hoc analysis (Dunnett test). The mean of each set of data was used in 
the statistical analysis. A probability level at p<0.05 was regarded as statistically significant. 
Differences between two experimental groups were tested by the unpaired Student t-test 
when comparing confounding factors due to gender, diet, smoking and drinking habits. The 
SPSS package version 16 was used to compare patient and control groups at different doses 
of H2O2, food mutagens and flavonoids. 
Statistical analyses were performed on mean values for each cluster group (healthy 
individuals, IBD and colon cancer patients) for each possible combination of chemicals. The 
experimental unit was the individual. The Comet data parameters used to measure DNA 
damage were Olive tail moment (OTM; arbitrary unit, the fraction of DNA in the tail 
multiplied by the tail length) and % tail DNA (the percentage of DNA in the tail) 
recommended to be the most reliable comet measurements with OTM being the most 
statistically significant (Kumaravel and Jha, 2006). Of these two parameters, OTM is one of 
the most commonly reported measures of DNA damage but is recommended to be provided 
together with % tail DNA (Tice et al., 2000). Together they clearly define the comets 
indicating a linear relationship to the DNA break frequency over a wide range of levels of 
damage and both can be applied for scientific purposes (Hartmann et al., 2003; Kumaravel et 
al., 2009). 
3. Results 
Mutagenic effects of food mutagens and H2O2 in lymphocytes of all groups, healthy 
individuals and IBD/cancer patients, were examined in vitro by comparing the untreated 
controls to the different treatment doses. Supplementing the treatment with various 
concentrations of the flavonoids, quercetin, epicatechin and rutin, the reduction of the 
genotoxic impact of chemicals was also evaluated. The different combined treatments of 
H2O2/food mutagens and flavonoids were then compared to a positive control being a non-
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supplemented high dose of H2O2/food mutagens. Subsequently, an intergroup comparison 
between healthy individuals and IBD/cancer patients was carried out evaluating the 
baseline DNA damage as well as the difference in sensitivity of lymphocytes of all groups. 
Also, the contribution of confounding factors was evaluated for all experiments. 
3.1 Study I: IBD patients 
3.1.1 Patient versus control groups  
As shown in Table 1 and Figure 1, there was a significant difference in baseline DNA damage 
before in vitro treatment in lymphocytes of IBD patients when comparing them with healthy 
individual controls (p < 0.001). The study groups as well as the control groups after treatment 
showed significant increases in DNA damage induced by H2O2 (p < 0.001) and IQ (p < 0.001). 
The induced damage caused by the in vitro treatment with H2O2 or IQ decreased significantly 
in both groups when co-treated with the flavonoids quercetin or epicatechin, respectively. 
Flavonoid supplementation at the highest concentration (250 μM quercetin or 100 μM 
epicatechin) caused an overall significant reduction of the induced DNA damage within the 
patient group and the control groups. This resulted in a 48.6% (p < 0.001) reduction of H2O2 
induced DNA damage and a 43% (p < 0.001) reduction of IQ induced DNA damage within 
the patient groups. For both control groups, reductions in DNA damage of 35.2% and 57.1%, 
respectively, were observed (both, p < 0.001) (Table 1 and Figure 1). As expected, the two 
different control groups showed similar baseline DNA damage (M-W, p = 0.174).  
 
 
 
 
 
 
 
 
Table 1. IBD patient/study and control groups, Olive tail moment (OTM) and % tail DNA 
after in vitro treatment with H2O2 and IQ and supplementation with the flavonoids at 
different concentration levels. A1, A2: No treatment; B1: H2O2 50 μM + Quercetin 0 μM ; B2: 
IQ 50 μM + Epicatechin 0 μM; C1: H2O2 50 μM + Quercetin 100 μM; C2: IQ 50 μM + 
Epicatechin 25 μM; D1: H2O2 50 μM + Quercetin 200 μM; D2: IQ 50 μM + Epicatechin 50 μM; 
E1: H2O2 50 μM + Quercetin 250 μM; E2: IQ 50 μM + Epicatechin 100 μM; 
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Fig. 1. IBD patient group and control group after in vitro treatment with A) H2O2 (50 μM) 
and supplementation with the flavonoid quercetin (Quer) at different concentration levels 
and B) IQ (50 μM) and supplementation with the flavonoid epicatechin (Epi) at different 
concentration levels. Pooling the data for each group and comparing median levels of DNA 
damage and 75% quartiles showed them to be significantly different (Kolmogorov-Smirnov 
test, p < 0.001). The  symbols followed by a number indicate individual outliers with the 
respective patient number.  
3.1.2 Differences in IBD sub-groups 
As shown in Table 2 and Figure 2 in both series of experiments there was less DNA damage 
in the UC patient group (n = 4) than in the CD group (n = 4) each being significantly 
different (Kruskal-Wallis (K-W) test, p < 0.001) when compared with the combined patient 
groups, which also included the indeterminate group where it was difficult to differentiate 
into UC or CD (n = 2). Also there was less induced DNA damage in the study group treated 
with H2O2 and quercetin compared with the study group treated with IQ and epicatechin 
although the patients were selected randomly.  
 
 
Fig. 2. DNA damage within three IBD subgroups after in vitro treatment with A) H2O2 (50 
μM) and supplementation with the flavonoid quercetin (Quer) at different concentration 
levels and B) IQ (50 μM) and supplementation with the flavonoid epicatechin (Epi) at 
different concentration levels. The first two groups were diagnosed with Crohn’s disease 
and Ulcerative Colitis. The third group was an indeterminate subgroup.  
BA 
A B 
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3.1.3 Confounding factors 
3.1.3.1 Ethnicity, age, gender, smoking and drinking habits 
There were small differences of median levels of DNA damage in Caucasians (n = 13) and 
Asians (n = 7) after treatment with H2O2 and quercetin as well as in males and females. A 
similar effect was observed within groups treated with IQ and epicatechin. However, these 
differences were not found to be statistically significant. There were also no statistically 
significant differences in DNA damage in the age distributions between patients as well as 
between control individuals (H2O2 with quercetin experiment: patients’ mean age = 42.4 
years ± 11.6, control individuals’ mean age = 28.9 years ± 9.0; IQ with epicatechin 
experiment: patients’ mean age = 39.2 years ± 10.3, control individuals’ mean age = 22.6 years 
± 9.2). No major differences were seen due to smoking and/or drinking habits (Table 2). 
 
Confounding 
factors 
H2O2 (0 µM) + Quercetin (0 µM) IQ (0 µM) + Epicatechin (0 µM) 
 Defining factors N OTM  p-value Defining factors N OTM  p-value 
Type of IBD
# 
Ulcerative colitis 
 
Crohn’s disease 
 
Indeterminate 
4 
 
4 
 
2 
5.3 ± 0.5 
 
9.8 ± 0.6 
 
7.3 ± 0.9 
p < 0.001 
Ulcerative colitis 
 
Crohn’s disease 
 
Indeterminate 
4 
 
4 
 
2 
3.5 ± 0.1 
 
7.3 ± 0.7 
 
7.0 ± 2.2 
p < 0.001 
Age
∆ 0-25 
 
26-45 
 
More than 46 
7 
 
8 
 
5 
7.9 ± 2.3 
 
11.3 ± 02 
 
13.0 ± 3.3 
p = 0.298 
0-25 
 
26-45 
 
More than 46 
7 
 
9 
 
4 
8.2 ± 0.5 
 
12.4 ± 2.5 
 
10.7 ± 0.1 
p = 0.395 
Smoking
∆ Active smokers 
 
Ex-smokers 
 
Non-smokers 
9 
 
3 
 
8 
12.4 ± 0.6 
 
7.3 ± 1.2 
 
9.5 ± 2.1 
p = 0.357 
Active smokers 
 
Ex-smokers 
 
Non-smokers 
9 
 
2 
 
9 
7.4 ± 3.2 
 
15.5 ± 0.3 
 
12.4 ± 1.1 
p = 0.090 
Drinking habit
∆ Non-alcoholic 
 
Moderate 
 
Severe 
7 
 
8 
 
5 
10.6 ± 1.1 
 
9.3 ± 0.8 
 
12.2 ± 0.4 
p = 0.704 
Non-alcoholic 
 
Moderate 
 
Severe 
10 
 
9 
 
1 
12.7 ± 1.0 
 
7.6 ± 4.2 
 
15.0 ± 0.7 
p = 0.123 
Ethnic origin
∆ Caucasian 
 
Asian 
13 
 
7 
10.6 ± 1.4 
 
10.3 ± 0.3 
p = 0.905 
Caucasian 
 
Asian 
12 
 
8 
9.8 ± 0.9 
 
11.6 ± 2.7 
p = 0.487 
Gender
∆ Female 
 
Male 
13 
 
7 
10.1 ± 2.2 
 
11.1 ± 0.9 
p = 0.700 
Female 
 
Male 
10 
 
10 
10.3 ± 3.0 
 
9.7 ± 2.3 
p = 0.838 
 
Table 2. Details of patient and control groups relating to confounding factors and their 
significant differences. OTM – Olive tail moment; # - only patient values included, values 
for healthy individuals shown in Table 1; ∆ - patient and control group values combined 
3.1.3.2 Previous medication in the IBD group as a confounding factor 
Patients had been treated with a range of drugs for IBD, namely, azathioprine, mesalazine 
and pentasa, asacol, prednisolone, mercaptopurine alone or in combination prior to taking 
part in the study. Azathioprine & pentasa, azathioprine & mesalazine, mercaptopurine & 
balsalazide (n = 6); asacol (n = 1); pentasa & prednisolone, prednisolone & mesalazine (n = 
3). Within the treatment groups, there appeared to be differences but they were not 
significant.  
3.2 Study II: colon cancer patients 
3.2.1 Patient versus control groups  
Treating lymphocytes from healthy individuals and cancer patients with food mutagens IQ 
and PhIP in vitro resulted in a dose-dependent statistically significant induction of DNA 
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damage for both parameters measured, Olive tail moment (OTM) and % tail DNA (Table 3). 
For the 25μM IQ treatment of lymphocytes from colon cancer patients, the induced DNA 
damage measured in % tail DNA reached significance while the evaluated OTM did not.  
 
 Healthy individuals Colon cancer patients Healthy individuals Colon cancer patients 
 Mean OTM ± SE % tail DNA ± SE 
     
Negative control 2.10 ± 0.30 4.10 ± 0.42 §§§ 10.95 ± 1.30 18.18 ± 1.25 §§§ 
25 µM IQ 3.23 ± 0.31 ** 4.84 ± 0.47 §§ 14.69 ± 1.01 ** 20.12 ± 1.26 * §§§ 
75 µM IQ 5.50 ± 0.38 *** 6.18 ± 0.40 *** 21.82 ± 1.27 *** 24.76 ± 1.23 ***  § 
100 µM IQ 6.03 ± 0.43 *** 6.97 ± 0.49 *** 23.98 ± 1.28 *** 25.90 ± 1.54 *** 
150 µM IQ 8.47 ± 0.58 *** 9.75 ± 0.53 *** § 33.80 ± 1.22 *** 35.52 ± 1.94 *** 
     
150 µM IQ and 100 µM Q 7.67 ± 0.51 7.24 ± 0.37 ††† 29.06 ± 1.05 †† 30.11 ± 1.48 † 
150 µM IQ and 250 µM Q 5.90 ± 0.46 ††† 7.32 ± 0.54 ††† 22.53 ± 1.62 ††† 28.86 ± 1.52 †† §§ 
150 µM IQ and 500 µM Q 3.44 ± 0.26 ††† 5.81 ± 0.71 † §§ 16.13 ± 1.16 ††† 24.57 ± 2.39 ††† §§ 
     
150 µM IQ and 50 µM R 7.76 ± 0.59 7.21 ± 0.37 ††† 27.42 ± 1.59 † 28.95 ± 1.13 †† 
150 µM IQ and 250 µM R 7.27 ± 0.47 † 6.63 ± 0.37 ††† 26.21 ± 1.32 †† 26.74 ± 1.20 ††† 
150 µM IQ and 500 µM R 4.12 ± 0.59 ††† 5.18 ± 0.50 ††† 15.98 ± 1.78 ††† 21.82 ± 1.38 ††† §§ 
     
     
Negative control 2.90 ± 0.36 3.55 ± 0.30 13.53 ± 1.30 16.51 ± 0.96 § 
10 µM PhIP 3.75 ± 0.41 4.38 ± 0.33 ** 16.92 ± 1.42 * 19.95 ± 1.20 ** § 
25 µM PhIP 5.57 ± 0.49 *** 5.41 ± 0.33 *** 23.31 ± 1.52 *** 24.15 ± 1.03 *** 
50 µM PhIP 5.70 ± 0.54 *** 7.07 ± 0.49 *** § 24.01 ± 1.58 *** 27.79 ± 1.36 *** § 
75 µM PhIP 8.58 ± 0.85 *** 8.27 ± 0.71 *** 31.05 ± 2.52 *** 33.79 ± 1.64 *** 
 
75 µM PhIP and 100 µM Q 6.80 ± 0.58 † 6.75 ± 0.53 † 27.16 ± 1.46 ††† 27.68 ± 1.36 †† 
75 µM PhIP and 250 µM Q 5.99 ± 0.58 †† 5.71 ± 0.49 †† 23.99 ± 1.68 ††† 24.35 ± 1.41 †† 
75 µM PhIP and 500 µM Q 3.72 ± 0.43 ††† 4.17 ± 0.45 ††† 16.73 ± 1.41 ††† 18.81 ± 1.50 ††† 
     
75 µM PhIP and 50 µM R 7.63 ± 0.56 7.25 ± 0.47 † 30.07 ± 1.79 29.28 ± 1.52 † 
75 µM PhIP and 250 µM R 6.39 ± 0.41 †† 6.39 ± 0.39 †† 25.38 ± 1.03 †† 27.13 ± 1.02 †† 
75 µM PhIP and 500 µM R 4.34 ± 0.30 ††† 5.85 ± 0.56 †† §  18.94 ± 0.72 ††† 24.36 ± 1.54 ††† §§   
Table 3. DNA damage induced in vitro in lymphocytes from healthy individuals and colon 
cancer patients by the food mutagens IQ and PhIP and its reduction by flavonoid 
supplementation with various concentrations of quercetin (Q) and rutin (R). 
Significantly different from the negative control: * p<0.05; ** p<0.01; *** p<0.001 
Significantly different from highest dose of food mutagen IQ: † p<0.05; †† p<0.01; ††† p<0.001 
Significantly different from healthy individuals: § p<0.05; §§ p<0.01; §§§ p<0.001 
Different concentrations of the flavonoids quercetin (100, 250 and 500 µM) and rutin (50, 250 
and 500 µM) showed modulating effects on human lymphocytes of both donor groups in the 
presence of high doses of food mutagens, 150 µM IQ or 75 µM PhIP (Table 3). In the majority 
of the experiments supplementation with flavonoids resulted in a significant dose-
dependent reduction of the induced DNA damage ranging from 1.4 to 2.5 times. For 
lymphocytes from healthy individuals, only the lowest quercetin dose together with IQ and 
the lowest dose for rutin together with IQ and PhIP measured in OTM, as well as the lowest 
dose of rutin together with PhIP when evaluating % tail DNA did not reach significant 
levels. At the highest supplemented flavonoid dose, the DNA damage from a high dose of 
food mutagen was significantly reduced to levels of damage in lymphocytes (from both 
donor groups) which was comparable to a treatment with a six times lower dose of the food 
mutagen IQ and a 7.5 times lower dose of PhIP, respectively. 
Intergroup comparisons showed lower basic DNA damage in lymphocytes from healthy 
individuals (negative control) when compared to those from colon cancer patients (Figure 3 
and Table 3). This difference was highly significant (p < 0.001 for parameters, OTM and % 
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tail DNA) for the negative control of the IQ experiment and significant for the PhIP 
experiment (p < 0.05 for % tail DNA; the OTM parameter did not reach significance: p = 
0.085). Also, after treatment with food mutagens IQ and PhIP this higher baseline damage 
led to a significantly higher induction of DNA damage in lymphocytes from cancer patients 
for IQ concentrations of 25 µM (p < 0.01 for OTM; p < 0.001 for % tail DNA), 75 µM (p < 0.05 
for % tail DNA) and 150 µM (p < 0.05 for OTM) as well as PhIP concentrations of 10 µM (p < 
0.05 for % tail DNA) and 50 µM (p < 0.05 for OTM & % tail DNA). 
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Fig. 3. The Comet parameter % tail DNA is shown indicating DNA damage in lymphocytes 
after in vitro treatment with IQ (25, 75, 100 and 150 µM) and then supplementation of the 
highest dose with either the flavonoid quercetin (Q) [Panel A] or rutin (R) [Panel B] as well 
as treatment with PhIP (10, 25, 50 and 75 µM) and then supplementation of the highest dose 
with either the flavonoid quercetin (Q) [Panel C] or rutin (R) [Panel D]. The flavonoids were 
used at different concentrations from 50 µM up to 500 µM. Intergroup comparisons of 
healthy individuals and colon cancer patients revealed significantly increased induction of 
DNA damage, when treating with heterocyclic amines alone and together with flavonoids, 
between healthy individuals and the colon cancer patient group (* p<0.05, ** p<0.01, *** 
p<0.001). All other types of data comparisons are shown in Table 3. 
When supplementing a single high-dose treatment of either IQ (150 µM) or PhIP (75 µM) 
with flavonoids (quercetin or rutin), the intergroup comparison showed only at the highest 
levels of flavonoid supplementation significant differences in the reduction of DNA damage 
caused by the food mutagen (Figure 3 and Table 3). Except for the supplementation of PhIP 
with 500 µM of quercetin (Figure 3C), lymphocytes from colon cancer patients showed 
significantly higher amounts of DNA damage at higher flavonoid concentrations in 
comparison to healthy volunteers (Figures 3A, 3B & 3D), i.e. less reduction of induced 
damage by the flavonoid (IQ + 500 µM quercetin, p < 0.01 for OTM and % tail DNA; IQ + 
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250 µM quercetin, p < 0.01 for % tail DNA; IQ + 500 µM rutin, p < 0.01 for % tail DNA; PhIP 
+ 500 µM rutin, p < 0.05 for OTM and p < 0.01 for % tail DNA). The parameter % tail DNA 
for genetic damage was more sensitive compared to OTM.  
3.2.2 Confounding factors 
Confounding factors such as age, gender, diet, smoking habits and alcohol intake were also 
investigated (Table 4). A significant higher baseline DNA damage (p < 0.001) in lymphocytes 
from colon cancer patients was observed for parameters OTM and % tail DNA compared to 
those from healthy individuals. There was also a significant difference between subjects of >50 
years of age when compared to those under 50 years of age (p < 0.01) showing a 1.80-fold and 
1.54-fold increased baseline DNA damage for OTM and % tail DNA, respectively. No 
statistically significant differences were found when focusing on smoking habits, alcohol 
intake and diet, although, when comparing Western to Asian/vegetarian type diet the OTM 
parameter almost reached significance (p = 0.061). DNA damage in male lymphocytes was 
significantly (p < 0.05) higher than in lymphocytes from females for the Comet assay 
parameter % tail DNA but not for the OTM parameter (p = 0.450).  
 
Confounding factor Sub-groups N Mean OTM ± SE % tail DNA ± SE Description 
Diagnosis 
Healthy  20 2.10 ± 0.30 10.95 ± 1.30 Colon cancer patients vs. 
healthy individuals Colon cancer 20 4.10 ± 0.42 *** 18.18 ± 1.25 *** 
Age∆ 
<50 years 18 2.02 ± 0.32 9.99 ± 1.38 
>50 vs. <50 years of age 
>50 years 22 3.64 ± 0.38 ** 15.42 ± 1.16 ** 
Smoking
∆ 
Active smokers 7 3.16 ± 0.85 12.12 ± 2.58 
Active / ex-smokers vs. non-
smokers 
Ex-smokers 16 2.69 ± 0.40 12.27 ± 1.52 
Non-smokers 17 2.99 ± 0.44 13.80 ± 1.54 
Drinking habit∆ 
Severe 15 3.20 ± 0.48 13.69 ± 1.60 
Severe / moderate drinking vs. 
no alcohol 
Moderate 14 2.85 ± 0.47 12.97 ± 1.79 
No alcohol 11 2.48 ± 0.54 11.66 ± 1.86 
Diet
∆ Western 25 3.22 ± 0.39 13.66 ± 1.38 Western vs. Asian/vegetarian 
diet Asian/vegetarian 15 2.30 ± 0.32 11.58 ± 1.23 
Gender∆ 
Female 17 2.50 ± 0.35 10.79 ± 1.07 
Female vs. male individuals 
Male 23 3.16 ± 2.97 14.39 ± 1.45 *  
Table 4. Confounding factors for healthy individuals and colon cancer patients and their 
influence on the baseline DNA damage using the Comet assay. Significantly different from 
the negative control: * p<0.05; ** p<0.01; *** p<0.001 . OTM - Olive tail moment; % tail DNA- 
fraction of DNA in the tail; ∆ - patient and control group values combined 
4. Discussion 
Crohn’s disease (CD) and Ulcerative Colitis (UC), known as inflammatory bowel disease 
(IBD), are fairly common chronic inflammatory conditions of the gastrointestinal tract. 
Although the exact aetiology of IBD remains uncertain, dysfunctional immunoregulation of 
the gut is believed to be the main cause. Amongst the immunoregulatory factors, reactive 
oxygen species (Seegert et al., 2001) are produced in abnormally high levels in IBD (Rezaie 
et al., 2007). An imbalance between antioxidants and ROS results in oxidative stress, leading 
to cellular damage (Rezaie et al., 2007) and subsequently cell death or cancer. Colorectal 
cancer is a heterogeneous neoplasm consisting of cancer cells with various proliferation 
rates and the potential to metastasise (Ozdemirler Erata et al., 2005). Genetic alterations 
caused by cellular overproduction of ROS are required for neoplastic progression 
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(Soderlund et al., 2010). Such changes are based on DNA damage triggered by endogenous 
but also by environmental and lifestyle genotoxins (Bartsch et al., 2002; Ozdemirler Erata et 
al., 2005). As the onset of cancer is a prolonged multi-stage process where successive 
mutations are accumulated, continuous erosion of the genome and defects in repair 
contribute to this process (Hoeijmakers, 2001; Jiricny and Marra, 2003). Several factors, 
depending on the socio-economical status, such as large amounts of salted, cured and 
smoked foods, dietary mutagens, alcohol and obesity may play an important role in 
increasing mutagenicity leading to an inappropriate stimulation of the immune response or 
release of ROS subsequently generating further DNA damage (Hursting et al., 2003). 
Cooking fish and beef inevitably generate HCA especially at high temperatures (Schut et al., 
1999), which are carcinogenic in mice, rats and monkeys producing hepatic, intestinal and 
mammary tumours (Schoeffner and Thorgeirsson, 2000) and posing a potential risk to 
humans. HCA have been widely investigated and all of them have so far been described as 
mutagenic and carcinogenic (Gooderham et al., 2007). Food-derived heterocyclic amines 
(HCA) like IQ have been shown to be mutagenic in the Ames test inducing gene mutations 
and tumours in vivo (Adamson and Thorgeirsson, 1995; Knize et al., 1995). Food mutagens 
may cause different types of DNA damage from chromosomal aberrations to subtle 
nucleotide alterations. Most food mutagens like HCA are able to form reactive DNA 
adducts by covalently binding to nucleotides. However the effect of food mutagens in 
carcinogenesis can be modified by heritable traits, namely, low-penetrant genes that affect 
exposure of the mutagen to DNA through metabolic activation and detoxification or other 
cellular responses to DNA damage. There is strong evidence that endogenous liver and 
kidney enzymes or those from commensal bacteria in the intestine are able to metabolically 
activate HCA which in turn generate DNA damage (El-Zein et al., 2006; Krul et al., 2000). 
Able to activate and detoxify heterocyclic amines may be enzymes like CYP1A2, N-
acetyltransferase, sulfotransferase, prolyl tRNA synthetase, phosphorylase and COX isomers 
(Wolz et al., 2000). In a recent case-control study, no associations were found between 
colorectal cancer (CRC) risk and polymorphisms within the genes of those enzymes (Sachse 
et al., 2002). This comprehensive analysis, however, failed to consider commensal bacteria 
and their potential impact on HCA activation, an effect independent of the host genotype. 
The pro-carcinogen IQ is predominantly produced through the pyrolysis of creatinine with 
sugars and becomes significantly mutagenic in the presence of hepatic microsomes 
(Sugimura and Sato, 1983). Anaerobic colonic bacteria can convert IQ to 2-amino-3-methyl-
3H-imidazo[4,5-f]quinoline-7-one (HOIQ), a direct-acting mutagen (Bashir et al., 1987). 
These commensal bacteria can strongly influence IQ-induced DNA damage in colonic cells 
and also in hepatocytes as measured by the alkaline comet assay (Knasmuller et al., 2001).  
As mentioned before DNA damage seems to be also triggered by oxidative stress. When 
considering the human diet, it should be recognized that food contains both, mutagens and 
components that decrease cancer risk such as antioxidants (Goldman et al., 2003; Maeda et 
al., 1999). Flavonoids are known to have antioxidative properties in vivo (Rice-Evans, 2001) 
and modulate effects of food mutagens in vitro in human lymphocytes and sperm (Anderson 
et al., 1998). Green tea and, to a lesser extent, black tea are a rich source of still another group 
of flavonoids called catechins. The activity of quercetin is believed to be due to its 
antioxidative properties, however, it has been suggested that quercetin may also have pro-
oxidative activities, which might then directly affect genotoxicity (Lee et al., 2003). 
Conclusively, quercetin acts as a strong antioxidant and scavenger of free radicals while it 
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might simultaneously undergo an oxidation process giving rise to the formation of the 
semiquinone radical (Papiez et al., 2008). 
The present studies demonstrate that H2O2, PhIP and IQ are capable of inducing significant 
DNA damage as a result of oxidative stress (Figures 1, 2 and 3, Table 1 and 3). There was a 
significant increase of DNA damage after treating lymphocytes from healthy controls, IBD 
and colon cancer patients with H2O2, PhIP and IQ, while a significant protective effect was 
found in the presence of the flavonoids quercetin, rutin and epicatechin (Figures 1, 2 and 3, 
Table 1 and 3). 
In the study I, the protective in vitro effect of quercetin and epicatechin against oxidative 
stress in lymphocytes from IBD patients and healthy individuals (Figure 1) was observed. 
We were able to show that untreated lymphocytes from IBD patients had significantly 
increased DNA damage when compared to healthy individuals as shown previously with 
other IBD patients (Najafzadeh et al., 2007). In vitro treatment with H2O2 and IQ significantly 
induced DNA damage by oxidative stress in both groups. Flavonoids reduced the baseline 
DNA damage in lymphocytes from IBD patients treated with H2O2 and IQ. Similar effects 
were achieved with Chaga mushroom extracts (Najafzadeh et al., 2007). When co-treated 
with flavonoids, a significant protective effect was shown against free radical damage to the 
DNA generated by H2O2 or IQ (Figure 1). There was a very high level of damage in the 
patient group without any treatment because of their background inflammation and IBD 
therapeutic drugs which they had taken, but both patients and controls showed a parallel 
and gradual reduction in DNA damage after treating with flavonoids (Figure 1 and Table 1).  
Lymphocytes from CD patients in two series of study groups appeared to have a greater 
level of baseline DNA damage than those from UC patients when compared to the whole 
patient group (p < 0.001) , suggesting that lymphocytes from CD patients are more exposed 
to oxidative stress than other IBD subgroups (Figure 2). It becomes obvious that an excessive 
production of ROS and radical nitrogen metabolites occur during the inflammation of the 
intestine in IBD patients (Kruidenier et al., 2003). It seems that a misbalanced production of 
pro-inflammatory and anti-inflammatory cytokines is characteristic of IBD and severely 
affects the immune homeostasis in peripheral blood cells, even more in CD than in UC 
patients (Sventoraityte et al., 2008). However, all subgroups react in the same way towards 
exogenous oxidative stressors as well as towards the inhibition of oxidative stress by 
flavonoids.  
The detrimental effects of two common food mutagens, IQ and PhIP, on the DNA were 
investigated in study II by treating in vitro lymphocytes from healthy individuals and from 
patients diagnosed with colon cancer. Pool-Zobel et al. found lymphocytes responses to be 
very similar to responses in rectal cells (Pool-Zobel et al., 2004), thus, supporting their role 
as surrogate cells for biomonitoring and in-vitro treatments. Both HCA caused in a dose-
dependent manner similar levels of DNA damage in lymphocytes of both groups for the 
Comet assay parameters OTM and % tail DNA (Table 3), supporting the classification for IQ 
as “probably carcinogenic to humans” and for PhIP as “possibly carcinogenic to humans” 
(IARC, 1993). Higher doses significantly increased the induced DNA damage. IQ and PhIP 
were shown to be potent genotoxins and carcinogens (Adamson et al., 1995; Durling and 
Abramsson-Zetterberg, 2005; Duthie et al., 1997). Even very low doses (10-3 to 10-4 µM PhIP) 
induce expression of the DNA damage response proteins like p53 and increase proliferation 
in oestrogen receptor (ER)-negative MCF10A cells (Gooderham et al., 2007). Hence, PhIP 
may induce/enhance carcinogenicity via DNA damage and/or oestrogen receptors 
(Bennion et al., 2005; Felton et al., 2004). IQ on the other hand can form DNA adducts like N-
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(deoxyguanosin-8-yl)-IQ in the presence of nitric oxide constituting a possible cancer risk for 
individuals with colon inflammation (Lakshmi et al., 2008).  
In our study the DNA damage induced in lymphocytes of both donor groups by food 
mutagens IQ and PhIP was effectively and dose-dependently reduced by supplementation 
with the flavonoids quercetin and rutin (Table 3). The level of DNA damage from the 
highest HCA dose reduced by the highest dose (500 µM) of flavonoids was comparable to 
that of a six times (for IQ) and 7.5 times (for PhIP) lower non-supplemented dose of food 
mutagen.  
Strong antioxidative effects of flavonoids to protect against DNA damage have been known 
for some time (Anderson et al., 2003; Collins, 2005; Perez-Vizcaino et al., 2009; Rice-Evans, 
2001) and in-vitro experiments on human colonocytes suggested that especially quercetin 
plays a crucial role in the defence against oxidative insults (Duthie and Dobson, 1999). In 
human lymphocytes quercetin and rutin already showed a dose-dependently protective 
effect against DNA damage caused by the mutagenic anticancer drug mitomycin C 
(Undeger et al., 2004). However, neither myricetin, quercetin nor rutin increased the rate of 
DNA strand break repair in various cell types such as Caco-2, Hep G2 and V79 (Aherne and 
O'Brien, 2000).  
We found that the number of individuals in each group was sufficient to establish 
statistically significant responses (p< 0.001) shown in our study for the food mutagens. Our 
results indicate that the baseline DNA damage was higher for all experiments in 
lymphocytes from colon cancer patients when compared to healthy individuals (Table 3 and 
Figure 3). Disease states which involve an overproduction of ROS may therefore inflict 
significantly higher DNA damage in peripheral lymphocytes from patients when compared 
to the baseline level of damage in healthy individuals. This has been shown for diseases like 
Irritable Bowel Syndrome and diabetes (Collins et al., 1998b; Najafzadeh et al., 2009; Wyatt, 
2006). It also confirms findings of Vodicka et al. who observed increased chromosomal 
damage in lymphocytes of newly diagnosed cancer patients compared with healthy controls 
(Vodicka et al., 2010). Similar observations of a higher baseline DNA damage were made for 
head and neck squamous cell carcinoma patients (Palyvoda et al., 2003) and breast cancer 
patients (Rajeswari et al., 2000; Smith et al., 2003) in addition to higher levels of cytogenetic 
damage (Palyvoda et al., 2003). Even the modulating effect of flavonoids in a co-treatment 
with a high dose of food mutagen (Table 3) seem to be affected by the higher baseline 
damage as the induced DNA damage in lymphocytes from colon cancer patients was not 
reduced to the levels of healthy individuals. Except for the supplementation of PhIP with 
500 µM of quercetin (Figure 3C), lymphocytes from colon cancer patients showed 
significantly higher amounts of DNA damage at higher flavonoid concentrations (Figures 
3A, 3B & 3D), i.e. less reduction of induced damage, that may suggest that higher 
concentrations of flavonoids would be required to achieve a protective effect. A possible 
reason for this finding could be a reduced repair capacity which was found for breast cancer 
patients after in-vitro treatment of lymphocytes with N-methyl-N-nitro-N-nitrosoguanidine 
or ionising radiation (Smith et al., 2003). The repair capacity of first degree relatives to these 
patients was also decreased (Rajeswari et al., 2000; Smith et al., 2003). These differences in 
repair capacity may either be an effect of cancer per se due to a changed lymphocyte 
population alongside the oncogenic process, or a higher DNA damage and slower repair 
among some individuals who may be more predisposed to develop cancer (Palyvoda et al., 
2003). 
An analysis of confounding factors such as age, gender, diet, smoking habits and alcohol 
intake (Table 4) on the baseline level of DNA damage in lymphocytes in Study II showed a 
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significant higher damage for subjects of >50 years of age (p < 0.01) as previously reported 
(King et al., 1994; Mendoza-Nunez et al., 2001). When examining the confounding effect 
aspects the numbers of participants were reduced yet we still found statistically significant 
effects for age (>50. p < 0.01) for both OTM and % tail DNA and for gender (males, p < 0.05) 
for % tail DNA only. An increase in DNA damage in lymphocytes has been observed among 
elderly individuals but was not significant (Betti et al., 1994; Mendoza-Nunez et al., 2001). 
We are aware our groups are not best matched for age however these were the only 
individuals available at the time. Despite this fact we were able to detect an age effect in a 
>50 age group. Although smoking and alcohol consumption is associated with an increased 
risk for colorectal cancer (Bardou et al., 2002; Emmons et al., 2005) probably due to DNA 
damage via increased levels of oxidative stress (Lodovici and Bigagli, 2009; Obe and 
Anderson, 1987; Pool-Zobel et al., 2004), no statistically significant differences were found in 
our study when focussing on smoking habits, alcohol intake or diet. This was also the case 
in the IBD study (Study I). DNA damage in male lymphocytes, however, was significantly 
higher than in lymphocytes from females for the Comet assay parameter % tail DNA but not 
for OTM. According to the literature, male gender constituted a risk factor for DNA damage 
(Collins et al., 1998a), where elderly males had more than twice the probability of having 
DNA damage than females (Mendoza-Nunez et al., 2001). After in vitro treatment with IQ 
and PhIP an increase in DNA damage in lymphocytes was observed in our study but 
confounding factors such as diet, smoking and drinking habits did not seem to influence 
this response, even though numerous environmental and lifestyle compounds can have an 
impact on the exposure, metabolism and cell proliferation response of HCA (Felton et al., 
2004). Nevertheless, in most of the cases the damage was similarly distributed and the 
general response to treatment may still be dependent on possible dietary interactions after 
exposure to food mutagens and individual factors like individual susceptibility, cellular 
antioxidant / micronutrient levels or disease states (Airoldi et al., 2004; El-Zein et al., 2006; 
Ferguson and Philpott, 2008; Han et al., 2008; Pool-Zobel et al., 2004). It has been estimated 
that up to 90% of the cases of colorectal cancer could be prevented with life style 
modifications such as balanced diet, avoidance of smoking and alcohol and physical activity 
(Boursi and Arber, 2007).  
5. Conclusion 
In conclusion, a significant protective effect of the flavonoids quercetin, epicatechin and 
rutin against oxidative DNA damage has been demonstrated after oxidative stress has been 
induced in vitro by H2O2, heterocyclic amines IQ and PhIP in lymphocytes obtained from 
IBD and colon cancer patients and healthy individuals. Lymphocytes from IBD, cancer 
patients and controls had increased DNA damage possibly due to an overproduction of 
ROS and there was a significant difference in response between all donor groups to 
treatment with HCA alone and together with flavonoids in both studies. It is believed that 
flavonoids operate through their antioxidant properties and responses of H2O2 and HCA to 
quercetin, epicatechin and rutin observed throughout the study, support the hypothesis that 
food mutagens target DNA by generating ROS. Concepts such as chemoprevention 
specifically focus on the long-term use of protective agents like vitamins (Boursi et al., 2007; 
Das et al., 2007). As shown, flavonoids have impressive antioxidant properties and are able 
to effectively protect the integrity of lymphocytes’ DNA from ROS induced by HCA, which 
would make them the ideal supplemental compounds to prevent the onset of cancer 
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(Dashwood, 1999; Ross et al., 2002). Although the possible health benefits of consuming 
flavonoids seem to be obvious, there are so many biological activities attributed to them, 
that further study may be justified. 
The flavonoids significantly reduce DNA damage in vitro in lymphocytes of IBD and 
colorectal cancer patients as well as healthy individuals. Thus, a diet containing flavonoids 
could be very effective in reducing baseline and exogenously induced oxidative DNA 
damage of IBD and colorectal cancer patients.  
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